4//SEC Filing
Amello Jason 4
Accession 0001209191-22-051131
CIK 0001841387other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 4:15 PM ET
Size
5.6 KB
Accession
0001209191-22-051131
Insider Transaction Report
Form 4
Amello Jason
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-09-21+230,000→ 230,000 totalExercise: $3.21Exp: 2032-09-21→ Common Stock (230,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on September 21, 2023, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Candel Therapeutics, Inc.
CIK 0001841387
Entity typeother
Related Parties
1- filerCIK 0001451805
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 4:15 PM ET
- Size
- 5.6 KB